Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications ...
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulom ...